Distinguishing Alzheimer's disease from normal pressure hydrocephalus: A search for MRI biomarkers

Journal of Alzheimer's Disease

Volumn 38, Issue 2, 2014, Pages 331-350

  Di Ieva, Antonio ^a   Valli, Mikaeel ^a   Cusimano, Michael D ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Alzheimer's disease; diagnostic imaging; idiopathic normal pressure hydrocephalus; magnetic resonance imaging; neuroimaging

Indexed keywords

BIOLOGICAL MARKER; CONTRAST MEDIUM;

ALZHEIMER DISEASE; ARTERIOVENOUS MALFORMATION; ARTICLE; BASAL CISTERN; BRAIN DAMAGE; BRAIN SIZE; BRAIN TISSUE; CEREBROSPINAL FLUID; CINGULATE SULCUS; CISTERNOGRAPHY; CLINICAL FEATURE; COGNITIVE DEFECT; CORTICAL THICKNESS (BRAIN); DIFFERENTIAL DIAGNOSIS; DIFFUSION TENSOR IMAGING; ELASTOGRAPHY; FRACTIONAL ANISOTROPY; GAIT DISORDER; GRAY MATTER; HIPPOCAMPUS; HUMAN; HYDRODYNAMICS; MORBIDITY; NEUROIMAGING; NEUROSURGERY; NORMOTENSIVE HYDROCEPHALUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PERFUSION WEIGHTED IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; QUALITY CONTROL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SUBARACHNOID SPACE; SUBICULUM; SUSCEPTIBILITY WEIGHTED IMAGING; SYLVIAN FISSURE; URINE INCONTINENCE; VASCULAR DISEASE; VEIN BLOOD FLOW; VISCOELASTICITY; VOXEL BASED MORPHOMETRY;

ALZHEIMER'S DISEASE; DIAGNOSTIC IMAGING; IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS; MAGNETIC RESONANCE IMAGING; NEUROIMAGING;

ALZHEIMER DISEASE; BRAIN; DATABASES, BIBLIOGRAPHIC; FEMALE; HUMANS; HYDROCEPHALUS, NORMAL PRESSURE; IMAGING, THREE-DIMENSIONAL; MALE; NEUROIMAGING;

EID: 84889581164     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130581     Document Type: Article

References (77)

1. Lindsay J, Sykes E, McDowell I,Verreault R, LaurinD(2004) More than the epidemiology of Alzheimer's disease: Contributions of the Canadian Study of Health and Aging. Can J Psychiatry 49, 83-91. (Pubitemid 38387417)
2. Fratiglioni L, Qiu C (2009) Prevention of common neurodegenerative disorders in the elderly. Exp Gerontol 44, 46-50.
3. Savica R, Petersen RC (2011) Prevention of dementia. Psychiatr Clin North Am 34, 127-145.
4. Marmarou A, Young HF, Aygok GA (2007) Estimated incidence of normal pressure hydrocephalus and shunt outcome in patients residing in assisted-living and extended-care facilities. Neurosurg Focus 22, E1.
5. Gallia GL, Rigamonti D,Williams MA (2006) The diagnosis and treatment of idiopathic normal pressure hydrocephalus. Nat Clin Pract Neurol 2, 375-381. (Pubitemid 43983775)
6. Bateman GA (2003) The reversibility of reduced cortical vein compliance in normal-pressure hydrocephalus following shunt insertion. Neuroradiology 45, 65-70. (Pubitemid 36700818)
7. Hebb AO, Cusimano MD (2001) Idiopathic normal pressure hydrocephalus: A systematic review of diagnosis and outcome. Neurosurgery 49, 1166-1186. (Pubitemid 32995855)
8. Silverberg GD (2004) Normal pressure hydrocephalus (NPH): Ischaemia, CSF stagnation or both. Brain 127, 947-948. (Pubitemid 38623032)
9. Beckmann NN, Schuler AA, Mueggler TT, Meyer EPE, Wiederhold K-HK, Staufenbiel MM, Krucker TT (2003) Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease. J Neurosci 23, 8453-8459.
10. Qiu C, Kivipelto M, Strauss Von E (2009) Epidemiology of Alzheimer's disease: Occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci 11, 111-128.
11. Dhenain M (2008) Preclinical MRI and NMR biomarkers of Alzheimer's disease: Concepts and applications. Magnetic Resonance Insights 2, 75-91.
12. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362, 329-344.
13. Hakim S, Adams RD (1965) The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci 2, 307-327.
14. Ott BR, Cohen RA, Gongvatana A, Okonkwo OC, Johanson CE, Stopa EG, Donahue JE, Silverberg GD, Alzheimer's Disease Neuroimaging, Initiative (2010) Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease. J Alzheimers Dis 20, 647-657.
15. Calcagni ML, Taralli S, Mangiola A, Indovina L, Lavalle M, De Bonis P, Anile C, Giordano A (2013) Regional cerebral metabolic rate of glucose evaluation and clinical assessment in patients with idiopathic normal-pressure hydrocephalus before and after ventricular shunt placement. Clin Nucl Med 38, 426-431.
16. Bateman GA (2008) The pathophysiology of idiopathic normal pressure hydrocephalus: Cerebral ischemia or altered venous hemodynamics AJNRAmJ Neuroradiol 29, 198-203.
17. Hamilton R, Patel S, Lee EB, Jackson EM, Lopinto J, Arnold SE, Clark CM, Basil A, Shaw LM, Xie SX, Grady MS, Trojanowski JQ (2010) Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology. Ann Neurol 68, 535-540.
18. Leinonen V, Menon LG, Carroll RS, Iacono DD, Grevet J, J̈äaskel̈ainen JE, Black PM (2011) Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus. Int J Alzheimers Dis 2011, 1-6.
19. Tarnaris A, Kitchen ND, Watkins LD (2009) Noninvasive biomarkers in normal pressure hydrocephalus: Evidence for the role of neuroimaging. J Neurosurg 110, 837-851.
20. Moore DW, Kovanlikaya I, Heier LA, Raj A, Huang C, Chu K-W, Relkin NR (2012) A pilot study of quantitative MRI measurements of ventricular volume and cortical atrophy for the differential diagnosis of normal pressure hydrocephalus. Neurol Res Int 2012, 1-6.
21. Lee W-J, Wang S-J, Hsu L-C, Lirng J-F, Wu C-H, Fuh J-L (2010) Brain MRI as a predictor of CSF tap test response in patients with idiopathic normal pressure hydrocephalus. J Neurol 257, 1675-1681.
22. Walter C, Hertel F, Naumann E, M̈orsdorf M (2005) Alteration of cerebral perfusion in patients with idiopathic normal pressure hydrocephalus measured by 3D perfusion weighted magnetic resonance imaging. J Neurol 252, 1465-1471. (Pubitemid 41803835)
23. Benzel EC, Pelletier AL, Levy PG (1990) Communicating hydrocephalus in adults: Prediction of outcome after ventricular shunting procedures. Neurosurgery 26, 655-660. (Pubitemid 20120715)
24. Ries ML, Carlsson CM, Rowley HA, Sager MA, Gleason CE, Asthana S, Johnson SC (2008) Magnetic resonance imaging characterization of brain structure and function in mild cognitive impairment: A review. J Am Geriatr Soc 56, 920-934. (Pubitemid 351652416)
25. Rinne JO,WongDF,WolkDA, LeinonenV, Arnold SE, Buckley C, Smith A, McLain R, Sherwin PF, Farrar G, Kailaj̈arvi M, Grachev ID (2012) [18F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid detection in living subjects with normal pressure hydrocephalus: Pooled analysis of four studies. Acta Neuropathol 124, 833-845.
26. Goto H, Ishii K, Uemura T, Miyamoto N, Yoshikawa T, Shimada K, Ohkawa S (2010) Differential diagnosis of dementia with Lewy bodies and Alzheimer disease using combinedMR imaging and brain perfusion single-photon emission tomography. AJNR Am J Neuroradiol 31, 720-725.
27. Walhovd KB, Fjell AM, Brewer J, McEvoy LK, Fennema-Notestine C, Hagler DJ, Jennings RG, Karow D, Dale AM, the Alzheimer's Disease Neuroimaging, Initiative (2010) Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease. AJNR Am J Neuroradiol 31, 347-354.
28. Van Heertum RL, Tikofsky RS (2003) Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia. Semin Nucl Med 33, 77-85. (Pubitemid 36169395)
29. Vemuri P, Wiste HJ, Weigand SD, Shaw LM, Trojanowski JQ, Weiner MW, Knopman DS, Petersen RC, Jack CR, Alzheimer's Disease Neuroimaging Initiative (2009)MRIand CSF biomarkers in normal, MCI, and AD subjects: Predicting future clinical change. Neurology 73, 294-301.
30. Al-Zain FT, Rademacher G, Meier U, Mutze S, Lemcke J (2008) The role of cerebrospinal fluid flow study using phase contrast MR imaging in diagnosing idiopathic normal pressure hydrocephalus. Acta Neurochir Suppl 102, 119-123.
31. Bateman GA, Loiselle AM (2007) Can MR measurement of intracranial hydrodynamics and compliance differentiate which patient with idiopathic normal pressure hydrocephalus will improve following shunt insertion Acta Neurochir (Wien) 149, 455-462. (Pubitemid 46669402)
32. Algin O, Hakyemez B, Taskapilioglu O, Ocakoglu G, Bekar A, Parlak M (2009) Morphologic features and flow void phenomenon in normal pressure hydrocephalus and other dementias. Acad Radiol 16, 1373-1380.
33. Algin O, Hakyemez B, Ocakoglu G, Parlak M (2010) MR Cisternography: Is it useful in the diagnosis of normal pressure hydrocephalus and the selection of "good shunt responders" Diagn Interv Radiol 17, 105-111.
34. Algin O, Hakyemez B, Parlak M (2010) The efficiency of PC-MRI in diagnosis of normal pressure hydrocephalus and prediction of shunt response. Acad Radiol 17, 181-187.
35. Holodny A, Waxman RR, George AEA, Rusinek HH, Kalnin AJA, de Leon MM (1998) MR differential diagnosis of normal-pressure hydrocephalus and Alzheimer disease: Significance of perihippocampal fissures. AJNR Am J Neuroradiol 19, 813-819. (Pubitemid 30415760)
36. Kitagaki H, Mori E, Ishii K, Yamaji S, Hirono N, Imamura T (1998) CSF spaces in idiopathic normal pressure hydrocephalus: Morphology and volumetry. AJNR Am J Neuroradiol 19, 1277-1284. (Pubitemid 30418672)
37. Watanabe T, Shiino A, Akiguchi I (2010) Absolute quantification in proton magnetic resonance spectroscopy is useful to differentiate amnesic mild cognitive impairment from Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord 30, 71-77.
38. Adachi M, Kawanami T, Ohshima F, Kato T (2006) Upper midbrain profile sign and cingulate sulcus sign: MRI findings on sagittal images in idiopathic normal-pressure hydrocephalus, Alzheimer's disease, and progressive supranuclear palsy. Radiat Med 24, 568-572. (Pubitemid 351194463)
39. Tosun D, Schuff N, Truran-Sacrey D, Shaw LM, Trojanowski JQ, Aisen P, Peterson R, Weiner MW (2010) Relations between brain tissue loss, CSF biomarkers, and the ApoE genetic profile: A longitudinal MRI study. Neurobiol Aging 31, 1340-1354.
40. Palm WM, Saczynski JS, van der Grond J, Sigurdsson S, Kjartansson O, Jonsson PV, Eiriksdottir G, Gudnason V, Admiraal-Behloul F, Launer LJ, van Buchem MA, Age, Gene/Environment Susceptibility-Reykjavik, Study (2009) Ventricular dilation: Association with gait and cognition. Ann Neurol 66, 485-493.
41. Ng SES, Low AMS, Tang KK, Chan YH, Kwok RK (2009) Value of quantitative MRI biomarkers (Evans' index, aqueductal flow rate, and apparent diffusion coefficient) in idiopathic normal pressure hydrocephalus. J Magn Reson Imaging 30, 708-715.
42. Yamashita F, Sasaki M, Takahashi S, Matsuda H, Kudo K, Narumi S, Terayama Y, Asada T (2010) Detection of changes in cerebrospinal fluid space in idiopathic normal pressure hydrocephalus using voxel-based morphometry. Neuroradiology 52, 381-386.
43. Scher AI, Xu Y, Korf ESC, White LR, Scheltens P, Toga AW, Thompson PM, Hartley SW, Witter MP, Valentino DJ, Launer LJ (2007) Hippocampal shape analysis in Alzheimer's disease: A population-based study. NeuroImage 36, 8-18. (Pubitemid 46629140)
44. Karow DS, McEvoy LK, Fennema-Notestine C, Hagler DJ, Jennings RG, Brewer JB, Hoh CK (2010) Relative capability of MR imaging and FDG PET to depict changes associated with prodromal and early Alzheimer disease. Radiology 256, 932-942.
45. Henneman WJP, Sluimer JD, Barnes J, van der Flier WM, Sluimer IC, Fox NC, Scheltens P, Vrenken H, Barkhof F (2009) Hippocampal atrophy rates in Alzheimer disease: Added value over whole brain volume measures. Neurology 72, 999-1007.
46. Savolainen SS, Laakso MPM, Palj̈arvi LL, Alafuzoff II, Hurskainen HH, Partanen KK, Soininen HH, Vapalahti MM (2000) MR imaging of the hippocampus in normal pressure hydrocephalus: Correlations with cortical Alzheimer's disease confirmed by pathologic analysis. AJNR Am J Neuroradiol 21, 409-414.
47. Risacher SL, Shen L,West JD, Kim S, McDonald BC, Beckett LA, Harvey DJ, Jack CR, Jr, Weiner MW, Saykin AJ (2010) Longitudinal MRI atrophy biomarkers: Relationship to conversion in the ADNI cohort. Neurobiol Aging 31, 1401-1418.
48. Tondelli M,Wilcock GK, Nichelli P, De Jager CA, Jenkinson M, Zamboni G (2012) Structural MRI changes detectable up to ten years before clinical Alzheimer's disease. Neurobiol Aging 33, 825.e25-825.e36.
49. Ishii K, Kanda T, Harada A, Miyamoto N, Kawaguchi T, Shimada K, Ohkawa S, Uemura T, Yoshikawa T, Mori E (2008) Clinical impact of the callosal angle in the diagnosis of idiopathic normal pressure hydrocephalus. Eur Radiol 18, 2678-2683.
50. Chavhan G, Babyn P, Thomas B, ShroffM, HaackeM(2009) Principles, techniques, and applications of T2 based MR imaging and its special applications. Radiographic 29, 1449.
51. Kim MJ, Seo SW, Lee KM, Kim ST, Lee JI, Nam DH, Na DL (2011) Differential diagnosis of idiopathic normal pressure hydrocephalus from other dementias using diffusion tensor imaging. AJNR Am J Neuroradiol 32, 1496-1503.
52. Hattori T, Yuasa T, Aoki S, Sato R, Sawaura H, Mori T, Mizusawa H (2011) Altered microstructure in corticospinal tract in idiopathic normal pressure hydrocephalus: Comparison with Alzheimer disease and Parkinson disease with dementia. AJNR Am J Neuroradiol 32, 1681-1687.
53. Hattori T, Sato R, Aoki S, Yuasa T, Mizusawa H (2012) Different patterns of fornix damage in idiopathic normal pressure hydrocephalus and Alzheimer disease. AJNR Am J Neuroradiol 33, 274-279.
54. Hong YJ, Yoon B, Shim YS, Cho AH, Lim SC, Ahn KJ, Yang DW(2010) Differences in microstructural alterations of the hippocampus in Alzheimer disease and idiopathic normal pressure hydrocephalus: A diffusion tensor imaging study. AJNR Am J Neuroradiol 31, 1867-1872.
55. Teipel SJ, Wegrzyn M, Meindl T, Frisoni G, Bokde ALW, Fellgiebel A, Filippi M, Hampel H, Kl̈oppel S, Hauenstein K, Ewers M, EDSD study, group (2012) Anatomical MRI and DTI in the diagnosis of Alzheimer's disease: A European multicenter study. J Alzheimers Dis 31(Suppl 3), S33-S47.
56. Ayaz M, Boikov AS, Haacke EM, Kido DK, Kirsch WM (2010) Imaging cerebral microbleeds using susceptibility weighted imaging: One step toward detecting vascular dementia. J Magn Reson Imaging 31, 142-148.
57. Charidimou A, J̈ager HR, Werring DJ (2012) Cerebral microbleed detection and mapping: Principles, methodological aspects and rationale in vascular dementia. Exp Gerontol 47, 843-852.
58. Di Ieva A, G̈od S, Grabner G, Grizzi F, Sherif C, Matula C, Tschabitscher M, Trattnig S (2013) Three-dimensional susceptibility-weighted imaging at 7 T using fractal-based quantitative analysis to grade gliomas. Neuroradiology 55, 35-40.
59. Di Ieva A, Grizzi F, Rognone E, Tse ZTH, Parittotokkaporn T, Rodriguez Y Baena F, Tschabitscher M, Matula C, Trattnig S, Rodriguezy Baena R (2010) Magnetic resonance elastography: A general overview of its current and future applications in brain imaging. Neurosurg Rev 33, 137-145.
60. Freimann FB, Streitberger K-J, Klatt D, Lin K, McLaughlin J, Braun J, Sprung C, Sack I (2011) Alteration of brain viscoelasticity after shunt treatment in normal pressure hydrocephalus. Neuroradiology 54, 189-196.
61. Shiino A (2004) Magnetic resonance spectroscopic determination of a neuronal and axonal marker in white matter predicts reversibility of deficits in secondary normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 75, 1141-1148. (Pubitemid 39005771)
62. Whitwell JL, Jack CR, Jr, Kantarci K, Weigand SD, Boeve BF, Knopman DS, Drubach DA, Tang-Wai DF, Petersen RC, Josephs KA (2007) Imaging correlates of posterior cortical atrophy. Neurobiol Aging 28, 1051-1061. (Pubitemid 46635917)
63. Hertel F, Walter C, Schmitt M, M̈orsdorf M, Jammers W, Busch H, Bettag M (2003) Is a combination of Tc-SPECT or perfusion weighted magnetic resonance imaging with spinal tap test helpful in the diagnosis of normal pressure hydrocephalus J Neurol Neurosurg Psychiatry 74, 479-484. (Pubitemid 36379371)
64. Oishi K, MielkeMM, Albert M, Lyketsos CG, Mori S (2011) The fornix sign: A potential sign for Alzheimer's disease based on diffusion tensor imaging. J Neuroimaging 22, 365-374.
65. Haller S, Bartsch A, Nguyen D, Rodriguez C, Emch J, Gold G, Lovblad KO, Giannakopoulos P (2010) Cerebral microhemorrhage and iron deposition in mild cognitive impairment: Susceptibility-weighted MR imaging assessment. Radiology 257, 764-773.
66. Thomas B, Somasundaram S, Thamburaj K, Kesavadas C, Gupta AK, Bodhey NK, Kapilamoorthy TR (2007) Clinical applications of susceptibility weighted MR imaging of the brain-a pictorial review. Neuroradiology 50, 105-116.
67. Kirsch W, McAuley G, Holshouser B, Petersen F, Ayaz M, Vinters HV, Dickson C, Haacke EM, BrittW, Larseng J, Kim I, Mueller C, Schrag M, Kido D (2009) Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis 17, 599-609.
68. Ii Y, Maeda M, Kida H, Matsuo K, Shindo A, Taniguchi A, TomimotoH(2013) In vivo detection of cortical microinfarcts on ultrahigh-field MRI. J Neuroimaging 23, 28-32.
69. Sankari SE, Fichten A, Gondry-Jouet C, Czosnyka M, Legars D, Deramond H, Baĺedent O (2012) Correlation between tap test and CSF aqueductal stroke volume in idiopathic normal pressure hydrocephalus. Acta Neurochir Suppl 113, 43-46.
70. Tarnaris A, Toma AK, Kitchen ND,WatkinsLD(2009) Ongoing search for diagnostic biomarkers in idiopathic normal pressure hydrocephalus. Biomarkers Med 3, 787-805.
71. Thies B, Truschke E,Morrison-Bogorad M, Hodes RJ (1999) Consensus report of the Working Group on: Molecular and biochemical markers of Alzheimer's disease. Neurobiol Aging 20, 101-116.
72. Ng SES, Low AMS, Tang KK, Lim WEH, Kwok RK (2009) Idiopathic normal pressure hydrocephalus: Correlating magnetic resonance imaging biomarkers with clinical response. Ann Acad Med Singap 38, 803-808.
73. Cabral D, Beach TG, Vedders L, Sue LI, Jacobson S, Myers K, Sabbagh MN (2011) Frequency of Alzheimer's disease pathology at autopsy in patients with clinical normal pressure hydrocephalus. Alzheimers Dement 7, 509-513.
74. Silverberg GD, Mayo M, Saul T, Rubenstein E, McGuire D (2003) Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: A hypothesis. Lancet Neurol 2, 506-511. (Pubitemid 36876108)
75. Leinonen V, Koivisto AM, Savolainen S, Rummukainen J, Tamminen JN, Tillgren T, Vainikka S, Pyykk̈o OT,M̈ols̈a J, FraunbergM, Pirttil̈a T, J̈äaskel̈ainen JE, Soininen H, Rinne J, Alafuzoff I (2010) Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease. Ann Neurol 68, 446-453.
76. Bech-Azeddine R, Hogh P, Juhler M, Gjerris F, Waldemar G (2007) Idiopathic normal-pressure hydrocephalus: Clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting. J Neurol Neurosurg Psychiatry 78, 157-161. (Pubitemid 46220213)
77. Silverberg GD, Mayo M, Saul T, Fellmann J, Carvalho J, McGuire D (2008) Continuous CSF drainage in AD: Results of a double-blind, randomized, placebo-controlled study. Neurology 71, 202-209.